Neoleum™, an extremely oil productive microorganism patented by Neol

by Neol Biosolutions

Thanks to its research in the area of biotechnology, Neol has developed the platform MicroBiOil® able to produce oils for industrial use from the processing of organic waste as well as industrial ...

Read more

IDIFARMA Extends Its GMP Clinical Manufacturing Services To New Dosage Forms

by Idifarma

IDIFARMA, a leading Spanish Contract Development and Manufacturing Organization, has recently obtained an extension of its authorization as GMP clinical manufacturer by the Spanish Medicines Agency...

Read more

Cordynamic offers infarction treatment solutions in Moscow

by IHT Innovative Health Technologies - Iberhospitex
  • 13 years ago

IHT Cordynamic actively participates in the 6th Russian Cardiology Forum held in Moscow on 28th and 29th November in order to consolidate its international position in Russia. The sixth edi...

Read more

Interview with Dámaso Molero, general manager in 3P

by 3PBIOVIAN

Dámaso Molero: “There are great opportunities in Latin America for the development of biosimilars“ Trescientas compañías han participado en el primer foro Biolatam, del sector biotecnoló...

Read more

Fórmulas innovadoras para sostener y hacer accesibles los tratamientos oncológicos

by AMGEN
  • 13 years ago

El cáncer continúa destacando en España y en Extremadura por su elevada magnitud y complejidad. En la comunidad extremeña, durante el año 2011, de los 10.500 casos de defunción registrados, lo...

Read more

Companies and business associations discussed in the CTNS future scenarios in the development of food supplements

by CTNS Centro Tecnológico de Nutrición y Salud

The ParaClaims Workshop was held in Reus on December 4th, 2013. The CTNS, AINS and AFEPADI Association showed how they can help many businesses in their developments and projects related to healthy ...

Read more

InKemia IUCT group consigue un gran proyecto europeo de I+D de 6,0 Millones de €

by InKemia IUCT group

Proyecto financiado por la EU que requiere una inversión en I+D de 7,9 M € para el desarrollo de una BioRefinería a partir de Glicerina residual de la fabricación del Biodiesel IUCT, la...

Read more

VivaCell enhances its R&D drug discovery program with the European Community’s FP7 TRIFORC Project

by VivaCell Biotechnology

European Union has under the 7th framework program allocated 6.9 Million Euro to the private-public TriForC consortium to establish an integrative and innovative pipeline for the development of n...

Read more

FERRER CREA UNA ALIANZA ESTRATÉGICA CON JANUS PARA IMPLEMENTAR UN NUEVO MODELO DE INVESTIGACIÓN EN LA INDUSTRIA FARMACÉUTICA ESPAÑOLA

by Janus Developments

La creación de SPHERIUM BIOMED permite a Ferrer segmentar su investigación para hacerla más eficiente y adaptable a las necesidades actuales. SPHERIUM BIOMED gestionará la amplia...

Read more

Iden Biotechnology S.L. (Spain) and Ingeniería Metabólica S.A. (INMET) (Argentina) sign commercial license and development agreement

by Iden Biotechnology
  • 13 years ago

Iden Biotechnology S.L., a Spanish R&D company and the Argentinean company Ingeniería Metabólica (INMET), today announced that they have signed an agreement for the development and licensing

Read more

NEOS signs a new commercial agreement in the US

by NEOS Surgery

NEOS Surgery and the multinational group KLS Martin have recently signed an exclusive commercial agreement for the Cranial LOOP family in the United States. With this contract, NEOS will take advanta...

Read more

CVRx® Closes $12 Million Additional Financing

by Ysios Capital

Minneapolis – October 30, 2013 – CVRx, Inc., a privately held medical device company, has closed on an additional $12 million under its Series F financing. This brings the total raised in the ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream